2[1]Kim A,Yun MO,Oh YK,et al.Pharmacodynamics of insulin in polyethylene glycol- coated liposomes[J].International Journal of Pharmaceutics.1999,180:72.
3[2]Christiane Damg Dominique Hillaire- Buys,Michele Koening,et al.Effect of n- hexacosanol on insulin secretion in the rat[J].European Journal of Pharmacology.1995,274:133- 139.
4[3]P.Sal Ch.Damg é ,A.S.Rivereau,et al.Insulin entrapped in isobutylcyanoacrylate nanocapsules redues the incidence of diabetes in nonobese diabetic mice[J].Journal of Autoimmunity.1996,9:713- 721.
5[4]S.Watnasirichaikul,T.Rades,I.G.Tucker.Effects of formulation variables on characteristics of poly(ethylcyanoacrylate)nanocapsules prepared from w/o microemulsions[J].International Journal of Pharmaceutics.2002,235:237- 246.
2[1]Kim A,Yun MO,Oh YK,et al.Pharmacodynamics of insulin in polyethylene glycol- coated liposomes[J].International Journal of Pharmaceutics.1999,180:72.
3[2]Christiane Damg Dominique Hillaire- Buys,Michele Koening,et al.Effect of n- hexacosanol on insulin secretion in the rat[J].European Journal of Pharmacology.1995,274:133- 139.
4[3]P.Sal Ch.Damg é ,A.S.Rivereau,et al.Insulin entrapped in isobutylcyanoacrylate nanocapsules redues the incidence of diabetes in nonobese diabetic mice[J].Journal of Autoimmunity.1996,9:713- 721.
5[4]S.Watnasirichaikul,T.Rades,I.G.Tucker.Effects of formulation variables on characteristics of poly(ethylcyanoacrylate)nanocapsules prepared from w/o microemulsions[J].International Journal of Pharmaceutics.2002,235:237- 246.
